Skip to content

A Study to Assess Virtual Reality by Healthcare Providers: A Pilot Study

Acceptability of Virtual Reality Experience by Health Care Providers for Improving Focus and Reducing Anxiety: A Pilot Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04622527
Enrollment
24
Registered
2020-11-10
Start date
2021-01-01
Completion date
2022-12-01
Last updated
2024-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Burn Out

Keywords

anxiety, burnout

Brief summary

The purpose of this study is to evaluate the acceptability of using Virtual Reality intervention to help reduce anxiety and burnout symptoms and improve focus in the workplace.

Detailed description

The proposed investigation will apply two novel paradigms using proprietary Virtual Reality interventions designed to reduce anxiety and inattention. We will explore whether this intervention is safe and acceptable, and whether it can impact the stress, anxiety, and difficulty in focus of employees in the workplace. Participants will view two different nature videos in two different formats. Each video will be experienced through Virtual Reality or non- Virtual Reality.

Interventions

OTHERRandom assigned paradigm viewing order

Participants experience the paradigm in a random order

Sponsors

Relay Therapeutics, Inc.
CollaboratorINDUSTRY
Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
SINGLE (Subject)

Masking description

Virtual Reality headgear and corresponding non-Virtual Reality are pre-programmed with paradigms. Participants were unaware of the order of the experience they will view.

Intervention model description

Participants viewed/were exposed to all 4 paradigms but in different sequence according to the randomization. With 4 paradigms there are a total of 24 ordering sequences. With a sample of N=24, each subject was randomized to one of these 24 sequences with each subject having a unique sequence.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years of age or older at the time of consent. * Healthcare Professional with the Mayo Clinic. * Not pregnant by participant self-report at time of consent. * Have the ability to provide informed consent. * Have no contraindicated comorbid health conditions as determined by the clinical investigators.

Exclusion criteria

* Currently (within the past 3 weeks) practicing mindfulness training on a weekly/regular basis. * Currently (within the past 3 weeks) undergoing an additional program (e.g., Complementary and Alternative Medicine \[CAM\]) to improve quality of life. * Currently (within 3 weeks) enrolled in another clinical or research program (e.g., CAM) which impacts the patients' quality of life (QOL), stress or anxiety. * Currently has photosensitivity. * Cannot tolerate virtual reality experiences. * An unstable medical or mental health condition as determined by the physician investigator (e.g., pre-existing eye strain, seizures, dizziness, nausea)

Design outcomes

Primary

MeasureTime frameDescription
State-Trait Anxiety Inventory (STAI Y1)2 weeksSTAI Y1 anxiety measurement of the change from post-test score to pre-test score. The STAI Y1 has 20 questions on a scale from 1 to 4. The minimum score is 20 and the maximum is 80. The lower the score the better the outcome. Our outcome looks at the difference between the post-test from the pre-test, so the minimum change score is -60 and the maximum change score is 60. A higher change in score would mean that a subject experienced a worse outcome after the paradigm, while a lower change in score shows a better outcome after the paradigm than before.

Secondary

MeasureTime frameDescription
Was the Study Worthwhile2 weeksAcceptability of Virtual Reality measured by a question from the satisfaction survey done at the end of the study. The question asked was Was it worthwhile for you to participate in this research study?.

Countries

United States

Participant flow

Pre-assignment details

The study included a total of 4 treatment interventions to which every participant was exposed. Subjects were randomized to one of the 24 unique treatment sequences.

Participants by arm

ArmCount
A = First Viewing of Virtual Reality Paradigm A
Begin with Paradigm A virtual reality headgear Random assigned paradigm viewing order: Participants experience all 4 paradigms in a random order beginning with Paradigm A with virtual reality headgear The 4 paradigms are: A = Virtual Reality Paradigm A, B = Virtual Reality Paradigm B, C = Non-Virtual Reality Paradigm A, D = Non-Virtual Reality Paradigm B
6
B = First Viewing of Virtual Reality Paradigm B
Begin with Paradigm B virtual reality headgear Random assigned paradigm viewing order: Participants experience all 4 paradigms in a random order beginning with Paradigm B with virtual reality headgear The 4 paradigms are: A = Virtual Reality Paradigm A, B = Virtual Reality Paradigm B, C = Non-Virtual Reality Paradigm A, D = Non-Virtual Reality Paradigm B
6
C = First Viewing of Non-Virtual Reality Paradigm A
Begin with Paradigm A without virtual reality headgear Random assigned paradigm viewing order: Participants experience all 4 paradigms in a random order beginning with Paradigm A through computer screen The 4 paradigms are: A = Virtual Reality Paradigm A, B = Virtual Reality Paradigm B, C = Non-Virtual Reality Paradigm A, D = Non-Virtual Reality Paradigm B
6
D = First Viewing of Non-Virtual Reality Paradigm B
Begin with Paradigm B without virtual reality headgear Random assigned paradigm viewing order: Participants experience all 4 paradigm in a random order beginning with Paradigm B through computer screen The 4 paradigms are: A = Virtual Reality Paradigm A, B = Virtual Reality Paradigm B, C = Non-Virtual Reality Paradigm A, D = Non-Virtual Reality Paradigm B
6
Total24

Baseline characteristics

CharacteristicB = First Viewing of Virtual Reality Paradigm BC = First Viewing of Non-Virtual Reality Paradigm AD = First Viewing of Non-Virtual Reality Paradigm BTotalA = First Viewing of Virtual Reality Paradigm A
Age, Continuous42.6 years
STANDARD_DEVIATION 5.2
49.0 years
STANDARD_DEVIATION 15.2
45.7 years
STANDARD_DEVIATION 12.5
46.3 years
STANDARD_DEVIATION 10.5
48.0 years
STANDARD_DEVIATION 7.7
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants1 Participants1 Participants6 Participants3 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants1 Participants1 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants1 Participants1 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
5 Participants5 Participants4 Participants16 Participants2 Participants
Sex: Female, Male
Female
2 Participants1 Participants3 Participants10 Participants4 Participants
Sex: Female, Male
Male
4 Participants5 Participants3 Participants14 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 240 / 240 / 240 / 24
other
Total, other adverse events
0 / 240 / 240 / 240 / 24
serious
Total, serious adverse events
0 / 240 / 240 / 240 / 24

Outcome results

Primary

State-Trait Anxiety Inventory (STAI Y1)

STAI Y1 anxiety measurement of the change from post-test score to pre-test score. The STAI Y1 has 20 questions on a scale from 1 to 4. The minimum score is 20 and the maximum is 80. The lower the score the better the outcome. Our outcome looks at the difference between the post-test from the pre-test, so the minimum change score is -60 and the maximum change score is 60. A higher change in score would mean that a subject experienced a worse outcome after the paradigm, while a lower change in score shows a better outcome after the paradigm than before.

Time frame: 2 weeks

Population: All 24 subjects experienced each of the 4 virtual reality paradigms. Before and after each paradigm, a STAI Y1 survey was given. The outcomes below shows the change between post and pre for all subjects, no matter what order they viewed the paradigm.

ArmMeasureValue (MEAN)Dispersion
A = Virtual Reality Paradigm AState-Trait Anxiety Inventory (STAI Y1)-6.4 units on a scaleStandard Deviation 5.98
B = Virtual Reality Paradigm BState-Trait Anxiety Inventory (STAI Y1)-5.8 units on a scaleStandard Deviation 9.29
C = Non-Virtual Reality Paradigm AState-Trait Anxiety Inventory (STAI Y1)-4.1 units on a scaleStandard Deviation 6.22
D = Non-Virtual Reality Paradigm BState-Trait Anxiety Inventory (STAI Y1)-5.0 units on a scaleStandard Deviation 6.89
Secondary

Was the Study Worthwhile

Acceptability of Virtual Reality measured by a question from the satisfaction survey done at the end of the study. The question asked was Was it worthwhile for you to participate in this research study?.

Time frame: 2 weeks

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
A = Virtual Reality Paradigm AWas the Study WorthwhileUnsure0 Participants
A = Virtual Reality Paradigm AWas the Study WorthwhileNo0 Participants
A = Virtual Reality Paradigm AWas the Study WorthwhileYes6 Participants
B = Virtual Reality Paradigm BWas the Study WorthwhileUnsure0 Participants
B = Virtual Reality Paradigm BWas the Study WorthwhileNo0 Participants
B = Virtual Reality Paradigm BWas the Study WorthwhileYes6 Participants
C = Non-Virtual Reality Paradigm AWas the Study WorthwhileNo1 Participants
C = Non-Virtual Reality Paradigm AWas the Study WorthwhileYes5 Participants
C = Non-Virtual Reality Paradigm AWas the Study WorthwhileUnsure0 Participants
D = Non-Virtual Reality Paradigm BWas the Study WorthwhileNo0 Participants
D = Non-Virtual Reality Paradigm BWas the Study WorthwhileUnsure1 Participants
D = Non-Virtual Reality Paradigm BWas the Study WorthwhileYes5 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026